AMT
30
2
DTE
49
16
APA
30
5
PWR
63
3
PLD
35
5
KSS
36
2
MET
58
2
KEY
24
2
KLAC
45
3
V
70
14
JPM
59
6
CMCSA
49
3
CMI
49
2
AES
47
4
AKAM
50
2
ORCL
49
3
DE
49
3
CTSH
55
3
GE
60
5
NWS
69
5
AMT
30
2
DTE
49
16
APA
30
5
PWR
63
3
PLD
35
5
KSS
36
2
MET
58
2
KEY
24
2
KLAC
45
3
V
70
14
JPM
59
6
CMCSA
49
3
CMI
49
2
AES
47
4
AKAM
50
2
ORCL
49
3
DE
49
3
CTSH
55
3
GE
60
5
NWS
69
5
Financhill
Back

Recon Technology 10K Form

Sell
17

RCON
Recon Technology

Last Price:
$2.13
Seasonality Move:
10.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RCON News And Ratings

See the #1 stock for the next 7 days that we like better than RCON

RCON Financial Statistics

Sales & Book Value

Annual Sales: $9.6M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $4.58
Price / Book: 0.86

Profitability

EPS (TTM): -1.40070
Net Income (TTM): $-6.9M
Gross Margin: $2.9M
Return on Equity: -11.14%
Return on Assets: -9.56%

Recon Technology Earnings Forecast

Key Recon Technology Financial Ratios

  • The Gross Profit Margin over the past 18 years for RCON is 30.32%.
  • The Selling, General & Administrative Expenses for RCON have been equal to 107.68% of Gross Profit Margin.
  • The Research & Development expenses have been 20.75% of Revenue.
  • The Interest Expense is -2.15% of Operating Income.
  • The Net Earning history of RCON is -72.43% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 12 years.

Recon Technology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Energy Equipment & Services
Sector: Energy
Current Symbol: RCON
CUSIP: G7415M
Website: recon.cn

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 10.67
Quick Ratio: 9.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RCON Technical Analysis vs Fundamental Analysis

Sell
17
Recon Technology (RCON) is a Sell

Is Recon Technology a Buy or a Sell?

  • Recon Technology stock is rated a Sell
    The current Recon Technology [RCON] share price is $2.13. The Score for RCON is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.